MNKD (Biotechnology) Stock Valuation & Fair Value Significantly overvalued
MNKD (Biotechnology) trades at a blended P/E of 1,546.5, about 1225% above its historical normal valuation, with a forward growth estimate of 501.0% and a PEG of 3.09.
Valuation flags
- Overvalued by 1225%
Frequently asked questions
Is MNKD overvalued?
At a blended P/E of 1,546.5 versus its historical normal P/E of 116.7, MNKD trades about 1225% above its typical valuation, with a PEG of 3.09 on 501.0% forward growth. tickerseer currently rates it significantly overvalued.
What is MNKD's fair value and PEG?
MNKD trades at a blended P/E of 1,546.5 against a historical normal P/E of 116.7, a PEG of 3.09, and a forward growth estimate of 501.0%.
Has tickerseer's rating of MNKD changed?
tickerseer's rating has been significantly overvalued since 2026-07-31.
Industry: Biotechnology. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.